Foundational Articles from MERIT Preclinical Experts

Knowing when ocular findings call for specialist review, choosing the right animal model, and matching species to program type are foundational decisions in ophthalmic drug development. In this series, Dr. Chris Murphy, board certified veterinary ophthalmologist, and CEO of OSOD, a MERIT Company, walks through what experienced teams rely on to get it right.

Let's Make Your
Project a Reality

Connect with us to learn more about how our expertise and approach can support bringing your product to market on-time and on-budget. Your success is our priority.